Gomez L, Hillaire M C, Jouany J P
I.N.R.A., Centre de Recherches de Clermont-Theix, Station de Recherches sur la Nutrition des Herbivores, Ceyrat-France.
Arch Tierernahr. 1990 Mar;40(3):229-38. doi: 10.1080/17450399009428398.
We investigated the capacity of a new ionophore antibiotic, abierixin, to modify fermentations in the rumen using a semi-continuous fermenter (Rusitec). As in the studies carried out on a "batch" fermenter (HILLAIRE et al., 1989a), abierixin failed to alter volatile fatty acids and gas productions but, in contrast, it limited the degradation of dietary nitrogen without affecting microbial synthesis. This molecule which has a low level of toxicity and is capable of improving the use of dietary proteins by ruminants, was found to be more effective when used at very low dose levels.
我们使用半连续发酵罐（瘤胃模拟技术装置，Rusitec）研究了一种新型离子载体抗生素阿比瑞新改变瘤胃发酵的能力。正如在“批次”发酵罐中进行的研究（HILLAIRE等人，1989a）一样，阿比瑞新未能改变挥发性脂肪酸和气体的产生，但相反，它限制了日粮氮的降解，同时不影响微生物合成。这种毒性水平较低且能够提高反刍动物对日粮蛋白质利用效率的分子，在非常低的剂量水平下使用时被发现更有效。
